The use of fermented buckwheat to produce L-carnitine enriched oyster mushroom [PMID: 30151668] Laboratory literature summary: The use of fermented buckwheat to produce L-carnitine enriched oyster mushroom
No standardized dosing, no manufacturing oversight, and no safety data outside controlled clinical trials where every vial and every dose was tracked
Make sure you read through the patient information leaflet carefully so you understand all of the necessary steps
Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
Starting with lower doses (5 grams or less) and gradually increasing intake can help minimize these effects
If you are pregnant: Ozempic should not be used during pregnancy